Five Prime Therapeutics, Inc. Variable Lease, Cost
Five Prime Therapeutics, Inc. reported Variable Lease, Cost of $2.42 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2021-03-22
- Five Prime Therapeutics, Inc. variable lease, cost for the quarter ending 2020-12-31 was $518.00K, a 12.12% increase year-over-year.
- Five Prime Therapeutics, Inc. variable lease, cost for the quarter ending 2020-09-30 was $500.00K, a 25.00% increase year-over-year.
- Five Prime Therapeutics, Inc. variable lease, cost for the quarter ending 2020-06-30 was $1.00M, a 100.00% increase year-over-year.
- Five Prime Therapeutics, Inc. variable lease, cost for the quarter ending 2020-03-31 was $500.00K, a 25.00% increase year-over-year.
- Five Prime Therapeutics, Inc. variable lease, cost for fiscal 2020 was $2.42M, a 37.23% increase from fiscal 2019.
- Five Prime Therapeutics, Inc. variable lease, cost for fiscal 2019 was $1.76M.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | $518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $1.02M derived: sum of 2 quarters · filed 2021-03-22 | $2.02M derived: sum of 3 quarters · filed 2021-03-22 | $2.42M 10-K · filed 2021-03-22 | |
| 2020-09-30 | $500.00K 10-Q · filed 2020-11-03 | $1.50M derived: sum of 2 quarters · filed 2020-11-03 | $1.90M 10-Q · filed 2020-11-03 | $2.46M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2020-06-30 | $1.00M 10-Q · filed 2020-08-06 | $1.50M 10-Q · filed 2020-08-06 | $1.96M derived: sum of 3 quarters · filed 2021-03-22 | $2.36M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2020-03-31 | $500.00K 10-Q · filed 2020-05-07 | $962.00K derived: sum of 2 quarters · filed 2021-03-22 | $1.36M derived: sum of 3 quarters · filed 2021-03-22 | $1.86M derived: sum of 4 quarters · filed 2021-03-22 | |
| 2019-12-31 | $462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $862.00K derived: sum of 2 quarters · filed 2021-03-22 | $1.36M derived: sum of 3 quarters · filed 2021-03-22 | $1.76M 10-K · filed 2021-03-22 | $1.80M 10-K · filed 2020-02-27 |
| 2019-09-30 | $400.00K 10-Q · filed 2020-11-03 | $900.00K derived: sum of 2 quarters · filed 2020-11-03 | $1.30M 10-Q · filed 2020-11-03 | ||
| 2019-06-30 | $500.00K 10-Q · filed 2020-08-06 | $900.00K 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $400.00K 10-Q · filed 2020-05-07 |